Randy Berholtz Insider Trading
Get free email notifications about insider trading for Randy Berholtz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Randy Berholtz. Randy Berholtz is an Executive VP & General Counsel in APRICUS BIOSCIENCES, INC. ($APRI) and a EVP, CORPORATE DEVELOPMENT in INNOVUS PHARMACEUTICALS, INC. ($INNV).
Address: 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO 92121 CA
Companies in which Randy Berholtz is an Insider
INNOVUS PHARMACEUTICALS, INC.
Trading Symbol: INNVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Randy Berholtz: EVP, CORPORATE DEVELOPMENT
Holdings: 4,990 shares
Current Value: $898
Latest Transaction: Apr 06 2018
$INNV Market Capitalization: $18.88M
$INNV Previous Close: $0.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEELOS THERAPEUTICS, INC.
Trading Symbol: SEELIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Randy Berholtz: Executive VP & General Counsel
Holdings: 5,769 shares
Current Value: $15,172
Latest Transaction: Aug 15 2011
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Randy Berholtz
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2018 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Option Exercise | A | 0.00 | 1,000,000 | 0 | 3,675,000 | |
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Option Exercise | A | 0.00 | 500,000 | 0 | 2,675,000 | |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 2,000 | 191 | 16,880 | 14.9 K to 16.9 K (+13.44 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,990 | 483 | 14,880 | 9.9 K to 14.9 K (+50.46 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,900 | 474 | 9,890 | 5 K to 9.9 K (+98.20 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,990 | 483 | 4,990 | 0 to 5 K |
Aug 15 2011 | APRI | APRICUS BIOSCIENCE ... | Berholtz Randy | Executive VP & Gene ... | Grant | A | 0.00 | 5,769 | 0 | 5,769 | 0 to 5.8 K |